Items where Author is "Farkas, K."

Article

Pallagi-Kunstár, É. and Farkas, K. and Maléth, J. and Rakonczay, Z. and Nagy, F. and Molnár, T. and Szepes, Z. and Venglovecz, V. and Lonovics, J. and Rázga, Z. and Wittmann, T. and Hegyi, P. (2014) Bile acids inhibit Na+/H+ exchanger and Cl−/HCO3 − exchanger activities via cellular energy breakdown and Ca2+ overload in human colonic crypts. Pflügers Archiv - European Journal of Physiology. ISSN 0031-6768

Kiss, L. S. and Szamosi, Tamás and Molnár, P. and Miheller, Pál and Lakatos, L. and Vincze, Á. and Palatka, Károly and Barta, Zoltán and Gasztonyi, Beáta and Salamon, Ágnes and Horváth, Gábor and Tóth, G. T. and Farkas, K. and Banai, János and Tulassay, Z. and Nagy, F. and Szenes, Mária and Veres, Gábor and Lovász, B. D. and Végh, Z. and Golovics, Petra Anna and Szathmári, Miklós and Papp, M. and Lakatos, P. L. (2011) Early clinical remission and normalisation of CRP are the strongest predictors of efficacy, mucosal healing and dose escalation during the first year of adalimumab therapy in Crohn's disease. Alimentary Pharmacology and Therapeutics, 34 (8). pp. 911-922. ISSN 0269-2813 (print), 1365-2036 (online)

Kiss, L. S. and Czeglédi, Z. and Miheller, P. and Molnár, T. and Lakatos, László and Vincze, Á. and Palatka, K. and Gasztonyi, Beáta and Salamon, Á. and Bartha, Z. and Horváth, G. and Tóth, G. T. and Farkas, K. and Szamosi, T. and Tulassay, Z. and Papp, M. and Altorjay, I. and Nagy, F. and Banai, J. and Lakatos, P. L. (2011) Predictors of efficacy, mucosal healing and need for dose intensification at 12-months of adalimumab therapy in patients with Crohn's disease. National data from Hungary. Journal of Crohn's and Colitis, 5 (S1). 573-P147. ISSN 1873-9946

Kiss, L. and Miheller, P. and Molnár, T. and Lakatos, L. and Vincze, Á. and Palatka, K. and Gasztonyi, B. and Salamon, Á. and Horvath, G. and Farkas, K. and Szamosi, T. and Banai, J. and Tulassay, Z. and Papp, M. and Lakatos, P. (2011) Predictors of efficacy, mucosal healing and dose intensification at 12-months of adalimumab therapy in patients with Crohn's disease. National data from Hungary. Zeitschrift für Gastroenterologie, 49. ISSN 0044-2771